263 - The investigational drug ZEN-3694, a novel BET-bromodomain inhibitor, inhibits multiple tumor immune escape mechanisms and has the potential to combine with immunotherapies
| Autor: | Attwell, S., Norek, K., Jahagirdar, R., Calosing, C., Lakhotia, S., Campeau, E., Hansen, H. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S88-S88 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect